Effort During Resistance Training in Type 2 Diabetes

Description

In this study the primary aims are to investigate the effect of resistance exercise training with different degrees of effort on glycemic control and psychological variables in individuals living with type 2 diabetes mellitus. As a secondary aim, investigate adherence and dropout rates and reasons for dropping out and adhering or not to the protocols.

Conditions

Type2 Diabetes Mellitus

Talk to us

Study Overview

On this page

Study Details

Study overview

In this study the primary aims are to investigate the effect of resistance exercise training with different degrees of effort on glycemic control and psychological variables in individuals living with type 2 diabetes mellitus. As a secondary aim, investigate adherence and dropout rates and reasons for dropping out and adhering or not to the protocols.

The Effect of Perceived Effort in Resistance Training on Glycemic Control and Psychological Responses in Individuals Living With Type 2 Diabetes Mellitus: a Randomized-controlled, Parallel Group, Clinical Trial

Effort During Resistance Training in Type 2 Diabetes

Condition
Type2 Diabetes Mellitus
Intervention / Treatment

-

Contacts and Locations

Albuquerque

UNM Exercise Physiology Lab, Albuquerque, New Mexico, United States, 87131-0001

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Living with type 2 diabetes mellitus
  • * Have a significant cognitive impairment,
  • * Are non-ambulatory,
  • * Have lower extremity amputation,
  • * Have renal failure,
  • * Have liver disease,
  • * Have uncontrolled hypertension (\>160 mmHg systolic and/or \>100 mmHg diastolic),
  • * Have unstable cardiovascular disease,
  • * Have a history of severe cardiovascular problems,
  • * Have decompensated heart failure,
  • * Have uncontrolled arrhythmias,
  • * Have severe pulmonary hypertension (mean pulmonary arterial pressure \>55 mm Hg),
  • * Have severe and symptomatic aortic stenosis,
  • * Have acute myocarditis, endocarditis, or pericarditis,
  • * Have aortic dissection,
  • * Have Marfan syndrome,
  • * Have unrepaired aortic aneurysm,
  • * Have proliferative diabetic retinopathy,
  • * Have rapidly progressive terminal illness,
  • * Are unable to perform resistance exercise to due preexisting musculoskeletal conditions (e.g., joint pain, chronic injury or tendinopathy),
  • * Are under biguanide (metformin) treatment, but are taking for less than 3 months,
  • * Have taken drugs known to increase the risk of tendon disorders (e.g., tendinopathy and tendon rupture) within the last 6 months. These drugs include, but may not be limited to: fluoroquinolones, glucocorticoids, aromatase inhibitors, anabolic steroids, antiretrovirals, isotretinoin, cephalexin, rituximab, sitagliptin, cephalosporins, azithromycin, and sulfonamides.
  • * Are pregnant or trying to become pregnant during the study,
  • * Are prisoners,
  • * Are persons that require a legally authorized representative.
  • * Being subjected to recent surgeries for which resistance training is not recommended,
  • * Have symptomatic hernias,
  • * Have acute illness,
  • * Have recent fractures, or other injuries until resolved.

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of New Mexico,

Flavio De Castro Magalhaes, PhD, PRINCIPAL_INVESTIGATOR, Assistant Professor

Study Record Dates

2026-02-01